Lycoramine HBr

CAS: 21133-52-8

Ref. 3D-FL12022

Produktinformation

• Name: Lycoramine HBr
• Synonyme: Dihydrogalanthamine HBr1,2-Dihydrogalanthamine, Dihydrogalanthamine, 1,2-Dihydrogalanthamine, (4aS,6S,8aS)-4a,5,7,8,9,10,11,12-Octahydro-3-methoxy-11-methyl-6H-benzofuro[3a,3,2-ef][2]benzazepin-6-ol, Lycoramine Hydrobromide
• CAS: 21133-52-8

Beschreibung

Lycoramine HBr is a cholinergic compound that has been used for the treatment of various conditions including gastroesophageal reflux disease and gastritis. It has also been shown to be effective in the treatment of Alzheimer's disease, Parkinson's disease, and Huntington's chorea. Lycoramine HBr is believed to act as an acetylcholinesterase inhibitor, which leads to increased levels of acetylcholine in the brain. The activity of Lycoramine HBr can be monitored by measuring chemiluminescence in tissue culture cells. This chemical can also be synthesized from haemanthamine and acetate extract with a small-molecule drug synthesis method known as asymmetric synthesis.

• Marke: Biosynth

Chemische Eigenschaften

• Molekulargewicht: 370.28 g/mol
• Formel: C₁₇H₂₄BrNO₃
• Reinheit: Min. 95%
• Farbe/Form: White Powder